Balchem Corporation manufactures and distributes specialty performance ingredients for nutritional, pharmaceutical, food, animal health, medical device sterilization, plant nutrition, and industrial applications. The company develops microencapsulation solutions, chelated minerals, vitamin K2, choline nutrients, and various delivery systems including spray-dried powders, emulsified systems, and flavor delivery platforms. It also distributes sterilization gases and fumigants used in healthcare and food processing industries.
The company operates through three segments. Human Nutrition and Health supplies ingredients to food and beverage manufacturers, including bases and systems for ice cream, cereal, chocolate, and dairy products, along with specialized nutritional compounds. Animal Nutrition and Health provides microencapsulated and chelated products for production and companion animals, focusing on nutrient absorption and health supplements. The Specialty Products segment distributes ethylene oxide and ammonia for healthcare sterilization, propylene oxide as a food fumigant, and chelated minerals for agricultural applications.
Balchem operates with approximately 1,350 full-time employees and serves customers worldwide through direct sales, independent distributors, and sales agents. The company was incorporated in 1967 and maintains headquarters in Montvale, New Jersey.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $1.21 | $1.23 | +17.5% | |
| 2024 | $1.03 | $1.05 | +25.6% | |
| 2023 | $0.82 | $0.83 | +24.2% | |
| 2022 | $0.66 | $0.67 | -13.2% | |
| 2021 | $0.76 | $0.78 | +11.8% | |
| 2020 | $0.68 | $0.69 | +7.9% | |
| 2019 | $0.63 | $0.64 | +0.0% | |
| 2018 | $0.63 | $0.63 | -51.5% | |
| 2017 | $1.30 | $1.31 | +160.0% | |
| 2016 | $0.50 | $0.51 | +2.0% | |
| 2015 | $0.49 | $0.50 | -19.7% | |
| 2014 | $0.61 | $0.62 | +74.3% | |
| 2013 | $0.35 | $0.36 | +6.1% | |
| 2012 | $0.33 | $0.34 | +6.5% | |
| 2011 | $0.31 | $0.33 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-20 | 0000009326-26-000007 | SEC ↗ |
| 2024-12-31 | 2025-02-21 | 0001628280-25-007202 | SEC ↗ |
| 2023-12-31 | 2024-02-16 | 0001628280-24-005397 | SEC ↗ |
| 2022-12-31 | 2023-02-24 | 0001628280-23-005074 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001628280-22-003669 | SEC ↗ |
| 2020-12-31 | 2021-02-19 | 0001628280-21-002578 | SEC ↗ |
| 2019-12-31 | 2020-02-21 | 0001628280-20-001968 | SEC ↗ |
| 2018-12-31 | 2019-02-28 | 0001628280-19-002288 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001140361-18-011267 | SEC ↗ |
| 2016-12-31 | 2017-02-28 | 0001140361-17-009655 | SEC ↗ |
| 2015-12-31 | 2016-02-29 | 0001140361-16-055524 | SEC ↗ |
| 2014-12-31 | 2015-02-27 | 0001140361-15-009362 | SEC ↗ |
| 2013-12-31 | 2014-02-27 | 0001140361-14-009932 | SEC ↗ |
| 2012-12-31 | 2013-02-25 | 0001140361-13-009071 | SEC ↗ |
| 2011-12-31 | 2012-02-29 | 0001140361-12-011682 | SEC ↗ |
| 2010-12-31 | 2011-02-28 | 0001140361-11-012692 | SEC ↗ |
| 2009-12-31 | 2010-03-12 | 0000914317-10-000421 | SEC ↗ |
| 2008-12-31 | 2009-03-12 | 0000914317-09-000630 | SEC ↗ |
| 2007-12-31 | 2008-03-17 | 0000914317-08-000792 | SEC ↗ |